These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anticipating full benefits from the new papillomavirus vaccines. Griffiths PD. Rev Med Virol; 2007; 17(1):1-3. PubMed ID: 17173349 [No Abstract] [Full Text] [Related]
4. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006]. Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe. Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273 [No Abstract] [Full Text] [Related]
7. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm]. Delvenne P. Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390 [Abstract] [Full Text] [Related]
11. Human papilloma virus infection and prevention in the adolescent population. Hager WD. J Pediatr Adolesc Gynecol; 2009 Aug; 22(4):197-204. PubMed ID: 19481480 [No Abstract] [Full Text] [Related]
12. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Brotherton JM, Leask J, Jackson C, McCaffery K, Trevena LJ. Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217 [Abstract] [Full Text] [Related]
13. Models of cervical screening in the era of human papillomavirus vaccination. Canfell K. Sex Health; 2010 Sep; 7(3):359-67. PubMed ID: 20719228 [Abstract] [Full Text] [Related]